Pinpointing molecular path that makes antidepressants act quicker in mouse model

Understanding alternate pathways for how mental meds work could lead to faster-acting drug targets

2013-09-14

(Press-News.org) PHILADELPHIA — The reasons behind why it often takes people several weeks to feel the effect of newly prescribed antidepressants remains somewhat of a mystery – and likely, a frustration to both patients and physicians.

Julie Blendy, PhD, professor of Pharmacology, at the Perelman School of Medicine, University of Pennsylvania; Brigitta Gunderson, PhD, a former postdoctoral fellow in the Blendy lab, and colleagues, have been working to find out why and if there is anything that can be done to shorten the time in which antidepressants kick in.

"Our goal is to find ways for antidepressants to work faster," says Blendy.

The proteins CREB and CREM are both transcription factors, which bind to specific DNA sequences to control the "reading" of genetic information from DNA to messenger RNA (mRNA). Both CREB and CREM bind to the same 8-base-pair DNA sequence in the cell nucleus. But, the comparative influence of CREM versus CREB on the action of antidepressants is a "big unknown," says Blendy.

CREB, and CREM to some degree, has been implicated in the pathophysiology of depression, as well as in the efficacy of antidepressants. However, whenever CREB is deleted, CREM is upregulated, further complicating the story.

Therefore, how an antidepressant works on the biochemistry and behavior in a mouse in which the CREB protein is deleted only in the hippocampus versus a wild type mouse in which CREM is overexpressed let the researchers tease out the relative influence of CREB and CREM on the pharmacology of an antidepressant. They saw the same results in each type of mouse line – increased nerve-cell generation in the hippocampus and a quicker response to the antidepressant. Their findings appear in the Journal of Neuroscience.

"This is the first demonstration of CREM within the brain playing a role in behavior, and specifically in behavioral outcomes, following antidepressant treatment," says Blendy.

A Flood of Neurotransmitters

Antidepressants like SSRIs, NRIs, and older tricyclic drugs work by causing an immediate flood of neurotransmitters like serotonin, norepinephrine, and in some cases dopamine, into the synaptic space. However, it can take three to four weeks for patients to feel changes in mental state. Long-term behavioral effects of the drugs may take longer to manifest themselves, because of the need to activate CREB downstream targets such as BDNF and trkB, or as of yet unidentified targets, which could also be developed as new antidepressant drug targets.

The Penn team compared the behavior of the control, wild-type mice to the CREB mutant mice using a test in which the mouse is trained to eat a treat – Reese's Pieces, to be exact – in the comfort of their home cage. The treat-loving mice are then placed in a new cage to make them anxious. They are given the treat again, and the time it takes for the mouse to approach the treat is recorded.

Animals that receive no drug treatment take a long time to venture out into the anxious environment to retrieve the treat, however, if given an antidepressant drug for at least three weeks, the time it takes a mouse to get the treat decreases significantly, from about 400 seconds to 100 seconds. In mice in which CREB is deleted or in mice in which CREM is upregulated, this reduction happens in one to two days versus the three weeks seen in wild-type mice.

The accelerated time to approach the treat in mice on the medication was accompanied by an increase in new nerve growth in the hippocampus.

"Our results suggest that activation of CREM may provide a means to accelerate the therapeutic efficacy of current antidepressant treatment," says Blendy. Upregulation of CREM observed after CREB deletion, appears to functionally compensate for CREB loss at a behavioral level and leads to maintained or increased expression of some CREB target genes. The researchers' next step is to identify any unique CREM target genes in brain areas such as the hippocampus, which may lead to the development of faster-acting antidepressants

INFORMATION:

Lisa A. Briand and Jennifer L. Onksen from the Department of Pharmacology, and John LeLay and Klaus H. Kaestner, from the Department of Genetics, were coauthors.

This work was supported by National Institute of Mental Health (U01MH0723832, T32-MH14654) and the National Cooperative Drug Discovery Group for the Treatment of Mood Disorders.

Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 16 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $398 million awarded in the 2012 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Penn Medicine also includes additional patient care facilities and services throughout the Philadelphia region.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2012, Penn Medicine provided $827 million to benefit our community.

ELSE PRESS RELEASES FROM THIS DATE:

Earth's wobble 'fixes' dinner for marine organisms

2013-09-14

The cyclic wobble of the Earth on its axis controls the production of a nutrient essential to the health of the ocean, according to a new study in the journal Nature. The discovery of factors that control this nutrient, known as "fixed" nitrogen, gives researchers insight into how the ocean regulates its own life-support system, which in turn affects the Earth's climate and the size of marine fisheries. Researchers from Princeton University and the Swiss Institute of Technology in Zurich (ETH) report that during the past 160,000 years nitrogen fixation rose and fell in ...

Warm ocean rapidly melting Antarctic ice shelf from below

2013-09-14

For five years, a scientific expedition tried reaching Pine Island Glacier ice shelf in a remote, wind-ridden corner of Antarctica. The obstacles to get to the ice shelf were extreme, but the science goal was simple: to measure how fast the sea was melting the 37-mile long ice tongue from underneath by drilling through the ice shelf. The international team, led by NASA's emeritus glaciologist Robert Bindschadler and funded by the National Science Foundation and NASA, had to abort their mission in 2007 due to logistical challenges after becoming the first people to ever ...

Insulin plays a role in mediating worms' perceptions and behaviors

2013-09-13

La Jolla, CA----In the past few years, as imaging tools and techniques have improved, scientists have been working tirelessly to build a detailed map of neural connections in the human brain---- with the ultimate hope of understanding how the mind works. But determining how cells in the brain are physically connected is only the first clue for decoding our perceptions and behaviors. We also need to know the precise routes that information takes in the brain in a given context. Now, publishing their results September 8 in the journal Nature Neuroscience, researchers at ...

Poxue Huayu and Tianjing Busui Decoction for cerebral hemorrhage

2013-09-13

Dr. Jixiang Ren and team from the Affiliated Hospital to Changchun University of Chinese Medicine proposed a therapeutic principle for Poxue Huayu and Tianjing Busui (i.e., breaking blood stasis, replenishing essence). The researchers established cerebral hemorrhage rat models which were intragastrically administered 5, 10, 20 g/kg Poxue Huayu and Tianjing Busui Decoction, supplemented with Hirudo, raw rhubarb, raw Pollen Typhae, gadfly, Fructrs Trichosanthis, Radix Notoginseng, Rhizoma Acori Talarinowii, and glue of tortoise plastron, once a day, for 14 consecutive days. ...

Why can prenatal alcohol exposure lead to fetal alcohol syndrome?

2013-09-13

Clinical literature and animal experiments have shown that prenatal alcohol exposure in utero, especially during the early stages of pregnancy, can cause fetal alcohol syndrome. The pharmacological and toxicological mechanisms of ethanol are considered to be related to the effects of ceramide. As an important signal transduction molecule, ceramide participates in a variety of cellular transduction pathways and can modulate cell cycle, cellular differentiation, proliferation, and apoptosis. A recent study, published in the Neural Regeneration Research (Vol. 8, No. 23, 2013), ...

Autophagy and neurodegenerative disorders

2013-09-13

Autophagy is a highly conserved process through the evolution of species, from eukaryotic microorganisms to humans. Bulky cytoplasmic contents, organisms (bacteria, viruses) and soluble proteins are degraded by autophagy and reused for the synthesis of new molecules. This process is generally induced by a change of environmental conditions, such as nutrient deprivation, oxidative stress and ultraviolet radiation. However, it has also been associated with normal procedures like development, differentiation and defence against pathogens. In spite of offering protection to ...

A clinician's guide to managing moral distress

2013-09-13

As health care reform takes shape in the U.S., vast amounts of attention have been given to the fact that more and more people with pre-existing illnesses will have access to professional care to relieve their physical and emotional suffering. Far less public attention has been given to the nurses and physicians who provide that care, and the authors of a recent study say there is evidence that many already experience serious "moral distress" that may interfere with their own health and their efforts on behalf of seriously ill and dying patients. "Studies and case histories ...

'Grassroots action' in livestock feeding to help curb global climate change

2013-09-13

SYDNEY, AUSTRALIA (13 September 2013)—In a series of papers to be presented next week, scientists offer new evidence that a potent chemical mechanism operating in the roots of a tropical grass used for livestock feed has enormous potential to reduce greenhouse gas emissions. Referred to as "biological nitrification inhibition" or BNI, the mechanism markedly reduces the conversion of nitrogen applied to soil as fertilizer into nitrous oxide, according to papers prepared for the 22nd International Grasslands Congress. Nitrous oxide is the most powerful and aggressive greenhouse ...

Model organism gone wild

2013-09-13

Model organisms, brought into labs because they are easy to work with, adapt to the lab, often shedding characteristics that allowed them to survive in the wild. Scientists who work with model organisms rarely look at the wild strains, but when they do, they can be surprised by what they find. This is what happened with the soil-living social amoeba, Dictyostelium discoideum, or Dicty. The single-celled amoebas crawl through the soil eating bacteria until food becomes scarce. Then the amoebas gather by the tens of thousands to form a multicellular slug, which transforms ...

Toward a truly white organic LED

2013-09-13

SALT LAKE CITY, Sept. 13, 2013 – By inserting platinum atoms into an organic semiconductor, University of Utah physicists were able to "tune" the plastic-like polymer to emit light of different colors – a step toward more efficient, less expensive and truly white organic LEDs for light bulbs of the future. "These new, platinum-rich polymers hold promise for white organic light-emitting diodes and new kinds of more efficient solar cells," says University of Utah physicist Z. Valy Vardeny, who led a study of the polymers published online Friday, Sept. 13 in the journal ...